News
Videos
Conferences
Events
Resources
Subscribe

|Videos|August 17, 2015

Antioxidant-rich Recipes for Cancer Patients

Episodes in this series

EP. 1 Obesity and Nutrition as Cancer Risk Factors

EP. 1 Obesity and Nutrition as Cancer Risk Factors

EP. 2 Navigating Supplements and Organic Foods

EP. 2 Navigating Supplements and Organic Foods

EP. 3 The Cooking Studio at JTCC

EP. 3 The Cooking Studio at JTCC

EP. 4 Appetite Stimulants and Nutritional Markers

EP. 4 Appetite Stimulants and Nutritional Markers

EP. 5 Cancer: Top Nutritional Tips

EP. 5 Cancer: Top Nutritional Tips

EP. 6 Specific Nutritional Tips for Individual Cancers

EP. 6 Specific Nutritional Tips for Individual Cancers

EP. 7 Antioxidant-rich Recipes for Cancer Patients

EP. 7 Antioxidant-rich Recipes for Cancer Patients

Image of woman, with text.

EP. 8 Emphasizing the Importance of Food Safety During Cancer Care

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Image of blood cells.

Chronic Myeloid Leukemia: From Diagnosis to Ongoing Management

January 18th 2026

Image of bonnie.

Taking Back the Razor: Choosing Power in the Face of Hair Loss

January 12th 2026

Mary Sansone

The Cancer Jam: Compassion and the Brain

January 5th 2026

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects.

IL-18-armored CAR T Drives Remissions in Relapsed B-Cell Leukemia

ByDr. Matthew P. Connor

December 19th 2025

$Bleximenib and Venclexta treatment were well tolerated in a phase 1b trial for relapsed or refractory acute myeloid leukemia with mostly low-grade side effects.$

Bleximenib/Venclexta Treatment Combo is Safe in Early AML Trial

ByDr. Jenny O’Nions

December 16th 2025

Trending on CURE

Blood Test May Predict Imdelltra Benefit in Small Cell Lung Cancer

Cancer Vaccine Plus Keytruda Reduces Melanoma Recurrence or Death

How A Cancer Vaccine and Keytruda Work to Treat Patients With Melanoma

Active Lifestyle Changes Following an MDS Diagnosis

FDA Grants Orphan Drug Designation to LP-284 for Soft Tissue Sarcoma